Notably, rapamycin or JAK2-inhibitor addition potentiated the inhibitory effect of sh-Lp-PLA2 on TNF-α and IL-6 secretion in Kupffer cells induced with NASH (P < 0.001; Fig. 5B). Here, JAK2 is linked to metabolic dysfunction-associated steatohepatitis.